CN Patent
CN120324437A — 低锌血症的治疗剂
Assigned to Nobelpharma Co ltd · Expires 2025-07-18 · 1y expired
What this patent protects
本发明提供一种低锌血症的治疗剂,特别是基于特定的用法、剂量的低锌血症的治疗剂。一种含有组氨酸锌或者其药学上可接受的盐或溶剂合物的低锌血症的治疗剂。
USPTO Abstract
本发明提供一种低锌血症的治疗剂,特别是基于特定的用法、剂量的低锌血症的治疗剂。一种含有组氨酸锌或者其药学上可接受的盐或溶剂合物的低锌血症的治疗剂。
Drugs covered by this patent
- Unithroid (LEVOTHYROXINE SODIUM) · Fresenius Kabi
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.